NM_001127222.2:c.3040G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001127222.2(CACNA1A):​c.3040G>A​(p.Glu1014Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00525 in 1,541,592 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1014D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 28 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

2
2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:11

Conservation

PhyloP100: 3.49

Publications

19 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0114197135).
BP6
Variant 19-13298593-C-T is Benign according to our data. Variant chr19-13298593-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194928.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00376 (573/152266) while in subpopulation NFE AF = 0.00578 (393/68014). AF 95% confidence interval is 0.00531. There are 0 homozygotes in GnomAd4. There are 266 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 573 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.3040G>Ap.Glu1014Lys
missense
Exon 19 of 47NP_001120694.1
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.3043G>Ap.Glu1015Lys
missense
Exon 19 of 47NP_001120693.1
CACNA1A
NM_023035.3
c.3052G>Ap.Glu1018Lys
missense
Exon 19 of 48NP_075461.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.3040G>Ap.Glu1014Lys
missense
Exon 19 of 47ENSP00000353362.5
CACNA1A
ENST00000638009.2
TSL:1 MANE Plus Clinical
c.3043G>Ap.Glu1015Lys
missense
Exon 19 of 47ENSP00000489913.1
CACNA1A
ENST00000638029.1
TSL:5
c.3052G>Ap.Glu1018Lys
missense
Exon 19 of 48ENSP00000489829.1

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
573
AN:
152150
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00578
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00356
AC:
514
AN:
144488
AF XY:
0.00375
show subpopulations
Gnomad AFR exome
AF:
0.000671
Gnomad AMR exome
AF:
0.00436
Gnomad ASJ exome
AF:
0.00232
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000772
Gnomad NFE exome
AF:
0.00605
Gnomad OTH exome
AF:
0.00545
GnomAD4 exome
AF:
0.00541
AC:
7523
AN:
1389326
Hom.:
28
Cov.:
32
AF XY:
0.00532
AC XY:
3645
AN XY:
685244
show subpopulations
African (AFR)
AF:
0.00107
AC:
32
AN:
29836
American (AMR)
AF:
0.00479
AC:
168
AN:
35084
Ashkenazi Jewish (ASJ)
AF:
0.00221
AC:
55
AN:
24836
East Asian (EAS)
AF:
0.0000294
AC:
1
AN:
33996
South Asian (SAS)
AF:
0.00109
AC:
86
AN:
78860
European-Finnish (FIN)
AF:
0.00102
AC:
50
AN:
49204
Middle Eastern (MID)
AF:
0.00194
AC:
11
AN:
5658
European-Non Finnish (NFE)
AF:
0.00633
AC:
6803
AN:
1074306
Other (OTH)
AF:
0.00551
AC:
317
AN:
57546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
420
840
1260
1680
2100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00376
AC:
573
AN:
152266
Hom.:
0
Cov.:
32
AF XY:
0.00357
AC XY:
266
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41570
American (AMR)
AF:
0.00562
AC:
86
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.000472
AC:
5
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00578
AC:
393
AN:
68014
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00496
Hom.:
7
Bravo
AF:
0.00427
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00570
AC:
35
ExAC
AF:
0.00200
AC:
62

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
4
not provided (7)
-
-
3
not specified (3)
-
-
1
CACNA1A-related disorder (1)
-
-
1
Developmental and epileptic encephalopathy, 42 (1)
-
-
1
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
Intellectual disability (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Benign
0.88
DEOGEN2
Benign
0.030
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.68
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.35
T
MutationAssessor
Benign
1.6
L
PhyloP100
3.5
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.25
Sift
Benign
0.41
T
Sift4G
Benign
0.33
T
Vest4
0.18
MVP
0.78
MPC
1.2
ClinPred
0.016
T
GERP RS
3.5
Varity_R
0.15
gMVP
0.34
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16024; hg19: chr19-13409407; API